AstraZeneca hails US trials but poll shows European worries

Washington (AFP) – Pharmaceutical giant AstraZeneca said Monday that US trials showed its Covid-19 vaccine was 100 percent effective in preventing severe disease, even as a poll showed trust in the jab had plunged in many European countries. The AstraZeneca shot is cheaper and easier to store than many of its rivals, but its use was thrown into chaos when several nations in Europe and other parts of the world last week suspended their rollouts because of isolated cases of blood clots. Vaccination drives are seen as crucial to overcoming the pandemic that has killed more than 2.7 million people…

Read More

HEDGE accordingly